1.
Atli E, Kalkan R, Mail C, Eker D, Demirci U, Demir S, et al. THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies. Mediterr J Hematol Infect Dis [Internet]. 2021 Jan. 1 [cited 2024 Apr. 24];13(1):e2021013. Available from: https://www.mjhid.org/mjhid/article/view/4432